CRYAA Gene Cataract, Autosomal Recessive Congenital Type 1 NGS Genetic Test
Short Name: CRYAA Cataract NGS
Also known as: Autosomal recessive congenital cataract type 1, CRYAA-related congenital cataract, CCA1, Congenital cataract type 1
CRYAA Gene Cataract, Autosomal Recessive Congenital Type 1 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are issued in 3 to 4 weeks after the sample is received by the laboratory.. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr SULOCHANA HEMCHANDRA HOLLA
Consultant Medical Geneticist · Reg: 8532
Last updated: September 7, 2026
Overview
The purpose of this NGS genetic test is to detect mutations in the CRYAA gene that are associated with autosomal recessive congenital type 1 cataract. It provides molecular evidence to confirm the diagnosis, support clinical management, and inform family counselling and recurrence risk. NGS genetic DNA test detecets for variant and mutation detection in CRYAA gene for Cataract, autosomal recessive congenital type 1
- Test Code
- 3799
- CPT Code
- Not specified
- ICD Code
- Q12.0
- Price
- ₹20,000
- Sample Type
- Blood or Extracted DNA or One drop Blood on FTA Card
- Result Time
- Reports are issued in 3 to 4 weeks after the sample is received by the laboratory.
- Fasting Required
- No
- Method
- Next Generation Sequencing (NGS)
- About CRYAA Gene Cataract
- Symptoms of CRYAA Gene Cataract
- Diagnosis of CRYAA Gene Cataract
- NGS Genetic DNA Test for CRYAA Gene Cataract
- Cost of CRYAA Gene Cataract Genetic DNA Test
About CRYAA Gene Cataract
CRYAA Gene Cataract, also known as autosomal recessive congenital type 1 cataract, is a rare genetic disorder that affects the lenses of the eyes. It is caused by a mutation in the CRYAA gene, which is responsible for producing a protein that helps maintain the transparency of the lens. Without this protein, the lens becomes cloudy, resulting in vision impairment and eventually blindness.
Symptoms of CRYAA Gene Cataract
The symptoms of CRYAA Gene Cataract usually become noticeable in infancy or early childhood. They include:
- Cloudy or opaque lenses
- Blurred vision
- Nearsightedness
- Abnormal eye movements
- Difficulty seeing in low light
Diagnosis of CRYAA Gene Cataract
Diagnosis of CRYAA Gene Cataract typically involves a comprehensive eye examination by an ophthalmologist. This may include:
- Visual acuity test
- Slit-lamp examination
- Dilated eye exam
- Family history evaluation
If CRYAA Gene Cataract is suspected, genetic testing may be recommended to confirm the diagnosis.
NGS Genetic DNA Test for CRYAA Gene Cataract
DNA Labs India offers a Next Generation Sequencing (NGS) Genetic DNA Test for CRYAA Gene Cataract. This test analyzes the CRYAA gene to detect any mutations that may be causing the cataracts. The test requires a small blood or saliva sample and results are typically available within 2-3 weeks.
Cost of CRYAA Gene Cataract Genetic DNA Test
The cost of the NGS Genetic DNA Test for CRYAA Gene Cataract offered by DNA Labs India is INR 20,000.
Contact DNA Labs India today to learn more about our genetic testing services.
Phone: +91-11-40849842
Email: info@dnamyway.com
Mutations in the CRYAA gene have been associated with a specific type of autosomal recessive congenital cataract, known as Cataract, Autosomal Recessive Congenital Type 1. Congenital cataracts are clouding of the lens of the eye that is present from birth and can significantly impact vision.
CRYAA (Crystallin Alpha A) is a gene that encodes a crystallin protein, which is a major structural component of the lens. The lens of the eye is normally transparent, allowing light to pass through and focus on the retina. Mutations in the CRYAA gene can disrupt the structure and function of the crystallin protein, leading to the development of cataracts.
Next-Generation Sequencing (NGS) Genetic DNA testing involves analyzing an individual's DNA to identify mutations or variations in specific genes associated with certain conditions, including autosomal recessive congenital cataracts due to CRYAA gene mutations.
The testing process generally includes:
Sample Collection: A sample of the individual's DNA is collected, usually through a blood sample or saliva.
DNA Sequencing: NGS technology is used to analyze the DNA sample. The genetic code is read to identify mutations or variations in the CRYAA gene.
Data Analysis: The genetic information is compared to reference sequences to detect deviations or mutations.
Results Interpretation: Genetic experts interpret the results to determine whether mutations in the CRYAA gene associated with congenital cataract type 1 are present.
Clinical Assessment: Genetic results are combined with clinical evaluation and other diagnostic tests to confirm the diagnosis of congenital cataract type 1 and guide treatment and management decisions.
Congenital cataracts can cause significant visual impairment and affect a person's quality of life. If you or someone you know is suspected of having congenital cataract type 1 due to CRYAA gene mutations, consulting with a pediatric ophthalmologist or healthcare provider who specializes in eye disorders is recommended. They can guide you through the decision-making process regarding genetic testing, provide information about the potential implications of the results, and offer recommendations for managing the condition and providing appropriate eye care. Early intervention, such as cataract surgery, may be necessary to improve vision and prevent further visual impairment.
Sample Collection
No fasting is required. A genetic counselling session is recommended before sample collection to document family history and draw a pedigree chart. A signed consent form and test requisition form should accompany the sample.
Method: Venepuncture / FTA card blood spot / DNA submission
Laboratory Analysis
For blood, a small sample is drawn into an EDTA vacutainer. For FTA card, a few drops of blood are placed on the printed circles and allowed to air dry. Extracted DNA may be submitted in a labelled vial.
Report Delivery
You may resume normal activities immediately. Keep the lab reference number for tracking. The report will be shared after 3 to 4 weeks through the selected delivery mode.
Timeline: Reports are issued in 3 to 4 weeks after the sample is received by the laboratory.
Patient Instructions
About This Test
Who Should Get This Test
The purpose of this NGS genetic test is to detect mutations in the CRYAA gene that are associated with autosomal recessive congenital type 1 cataract. It provides molecular evidence to confirm the diagnosis, support clinical management, and inform family counselling and recurrence risk.
NGS genetic DNA test detecets for variant and mutation detection in CRYAA gene for Cataract, autosomal recessive congenital type 1
How to Prepare
- No fasting is required for this DNA test.
- Ensure the sample vial or FTA card is labelled with the patient's name and ID.
- Submit the signed consent form and a genetic counselling referral or pedigree chart.
Doctor's Notes
Reviewed by Dr SULOCHANA HEMCHANDRA HOLLA — MBBS, MD (Medical Genetics) · Reg. No. 8532
"In families with an affected child, accurate recurrence risk estimation is essential. A confirmed CRYAA mutation allows parents to understand the chance of recurrence in future pregnancies and plan prenatal/preimplantation genetic diagnosis if desired."
Last updated: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Unlabelled or mismatched sample
- Clotted or haemolysed blood sample
- Insufficient sample quantity
- Sample without signed consent or genetic counselling form
Understanding Your Results
Pathogenic or likely pathogenic variant in CRYAA
Confirms molecular diagnosis of CRYAA-related autosomal recessive congenital type 1 cataract.
No pathogenic variant detected
No CRYAA mutation was found; other genetic or non-genetic causes should be considered.
Variant of uncertain significance
The variant cannot yet be confidently classified; additional family studies and clinicopathological correlation are required.
Consult a paediatric ophthalmologist or a clinical geneticist if a child has bilateral congenital cataract, unexplained lens opacity in infancy, or a family history of inherited cataract. Genetic counselling is recommended before and after this test.
Limitations
- ⚠This test analyses only the CRYAA gene and does not definitively exclude other genetic causes of congenital cataract.
- ⚠Large structural variants or deep intronic mutations may not be detected by routine NGS.
- ⚠A variant of uncertain significance may require additional family testing.
- ⚠Results should be interpreted with ophthalmological examination and genetic counselling.
Risks & Considerations
- ●Minor bruising or discomfort at the blood collection site
- ●Rare bleeding or infection at the puncture site
- ●Possible psychological impact of a genetic diagnosis
- ●Incidental genetic findings may require further counselling
Interfering Factors
- ●Sample degradation or contamination
- ●PCR inhibitors due to improper storage
- ●Mislabelled or mixed-up samples
- ●Low DNA concentration or quality
Compare With Similar Tests
| Test | CRYAA Gene Cataract, Autosomal Recessive Congenital Type 1 NGS Genetic Test | |||
|---|---|---|---|---|
| Comparison | CRYAA Gene Cataract, Autosomal Recessive Congenital Type 1 NGS Genetic Test |
Related Tests
Leber's Hereditary Optic Neuropathy (LHON) Mitochondrial Mutation Detection Test
₹25,000Nx Gen Sequencing: Cataract Test
₹28,665Nx Gen Sequencing: Glaucoma Test
₹28,665Nx Gen Sequencing: Corneal Dystrophy Test
₹28,665Nx Gen Sequencing: Leber Congenital Amaurosis Test
₹28,665Nx Gen Sequencing: Ophthalmoplegia Test
₹28,665Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.